Background/Objectives: PET imaging of bacterial infection could potentially provide added benefits for patient care through non-invasive means. [68Ga]Ga-desferrioxamine B-a radiolabelled siderophore-shows specific uptake by human-pathogenic bacteria like Staphylococcus aureus or Pseudomonas aeruginosa and sufficient serum stability for clinical application. In this report, we present data for automated production of [68Ga]Ga-desferrioxamine B on two different cassette-based synthesis modules (Modular-Lab PharmTracer and GRP 3V) utilising commercially obtainable cassettes together with a licensed 68Ge/68Ga radionuclide generator. Methods: Quality control, including the determination of radiochemical purity, as well as a system suitability test, was set up via RP-HPLC on a C18 column. The two described production processes use an acetic acid/acetate buffer system with ascorbic acid as a radical scavenger for radiolabelling, yielding ready-to-use formulations with sufficient activity yield. Results: Batch data analysis demonstrated radiochemical purity of >95% by RP-HPLC combined with ITLC and excellent stability up to 2 h after synthesis. Specifications for routine production were set up and validated with four masterbatches for each synthesis module. Conclusions: Based on this study, an academic clinical trial for imaging of bacterial infection was initiated. Both described synthesis methods enable automated production of [68Ga]Ga-desferrioxamine B in-house with high reproducibility for clinical application.

Department of Nuclear Medicine Medical University Innsbruck Anichstrasse 35 A 6020 Innsbruck Austria

Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University CZ 77900 Olomouc Czech Republic

Institute of Molecular Biology Biocenter Medical University of Innsbruck A 6020 Innsbruck Austria

Institute of Nuclear Medicine and Endocrinology Kepler University Hospital Krankenhausstrasse 9 A 4021 Linz Austria

Medical Faculty Johannes Kepler University Linz Altenberger Strasse 69 A 4040 Linz Austria

See more in PubMed

Haque M., Sartelli M., McKimm J., Abu Bakar M. Health Care-Associated Infections—An Overview. Infect. Drug Resist. 2018;11:2321–2333. doi: 10.2147/IDR.S177247. PubMed DOI PMC

Miller W.R., Arias C.A. ESKAPE Pathogens: Antimicrobial Resistance, Epidemiology, Clinical Impact and Therapeutics. Nat. Rev. Microbiol. 2024;22:598–616. doi: 10.1038/s41579-024-01054-w. PubMed DOI

Gerace E., Mancuso G., Midiri A., Poidomani S., Zummo S., Biondo C. Recent Advances in the Use of Molecular Methods for the Diagnosis of Bacterial Infections. Pathogens. 2022;11:663. doi: 10.3390/pathogens11060663. PubMed DOI PMC

Lawal I., Zeevaart J., Ebenhan T., Ankrah A., Vorster M., Kruger H.G., Govender T., Sathekge M. Metabolic Imaging of Infection. J. Nucl. Med. 2017;58:1727–1732. doi: 10.2967/jnumed.117.191635. PubMed DOI

Sollini M., Lauri C., Boni R., Lazzeri E., Erba P.A., Signore A. Current Status of Molecular Imaging in Infections. Curr. Pharm. Des. 2018;24:754–771. doi: 10.2174/1381612824666180110103348. PubMed DOI

Alberto S., Ordonez A.A., Arjun C., Aulakh G.K., Beziere N., Dadachova E., Ebenhan T., Granados U., Korde A., Jalilian A., et al. The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection. J. Nucl. Med. 2023;64:1676–1682. doi: 10.2967/jnumed.123.265906. PubMed DOI PMC

Hider R.C., Kong X. Chemistry and Biology of Siderophores. Nat. Prod. Rep. 2010;27:637–657. doi: 10.1039/b906679a. PubMed DOI

Skaar E.P. The Battle for Iron between Bacterial Pathogens and Their Vertebrate Hosts. PLoS Pathog. 2010;6:e1000949. doi: 10.1371/journal.ppat.1000949. PubMed DOI PMC

Wandersman C., Delepelaire P. Bacterial Iron Sources: From Siderophores to Hemophores. Annu. Rev. Microbiol. 2004;58:611–647. doi: 10.1146/annurev.micro.58.030603.123811. PubMed DOI

Fadeev E.A., Luo M., Groves J.T. Synthesis, Structure, and Molecular Dynamics of Gallium Complexes of Schizokinen and the Amphiphilic Siderophore Acinetoferrin. J. Am. Chem. Soc. 2004;126:12065–12075. doi: 10.1021/ja048145j. PubMed DOI

Petrik M., Umlaufova E., Raclavsky V., Palyzova A., Havlicek V., Pfister J., Mair C., Novy Z., Popper M., Hajduch M., et al. 68Ga-Labelled Desferrioxamine-B for Bacterial Infection Imaging. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:372–382. doi: 10.1007/s00259-020-04948-y. PubMed DOI PMC

Misslinger M., Petrik M., Pfister J., Hubmann I., Bendova K., Decristoforo C., Haas H. Desferrioxamine B-Mediated Pre-Clinical In Vivo Imaging of Infection by the Mold Fungus Aspergillus Fumigatus. J. Fungi. 2021;7:734. doi: 10.3390/jof7090734. PubMed DOI PMC

Nelson B.J.B., Andersson J.D., Wuest F., Spreckelmeyer S. Good Practices for 68Ga Radiopharmaceutical Production. EJNMMI Radiopharm. Chem. 2022;7:27. doi: 10.1186/s41181-022-00180-1. PubMed DOI PMC

Kollaard R., Zorz A., Dabin J., Covens P., Cooke J., Crabbé M., Cunha L., Dowling A., Ginjaume M., McNamara L. Review of Extremity Dosimetry in Nuclear Medicine. J. Radiol. Prot. 2021;41:R60. doi: 10.1088/1361-6498/ac31a2. PubMed DOI

Boschi S., Malizia C., Lodi F. Overview and Perspectives on Automation Strategies in (68)Ga Radiopharmaceutical Preparations. Recent. Results Cancer Res. 2013;194:17–31. doi: 10.1007/978-3-642-27994-2_2. PubMed DOI

Korde A., Mikolajczak R., Kolenc P., Bouziotis P., Westin H., Lauritzen M., Koole M., Herth M.M., Bardiès M., Martins A.F., et al. Practical Considerations for Navigating the Regulatory Landscape of Non-Clinical Studies for Clinical Translation of Radiopharmaceuticals. EJNMMI Radiopharm. Chem. 2022;7:18. doi: 10.1186/s41181-022-00168-x. PubMed DOI PMC

Gillings N., Hjelstuen O., Ballinger J., Behe M., Decristoforo C., Elsinga P., Ferrari V., Peitl P.K., Koziorowski J., Laverman P., et al. Guideline on Current Good Radiopharmacy Practice (CGRPP) for the Small-Scale Preparation of Radiopharmaceuticals. EJNMMI Radiopharm. Chem. 2021;6:8. doi: 10.1186/s41181-021-00123-2. PubMed DOI PMC

European Pharmacopoeia . GALLIUM (68Ga) EDOTREOTIDE INJECTION. 01/2022:2482. 11th ed. EDQM Council of Europe; Strasbourg, France: 2022.

European Pharmacopoeia . GALLIUM (68Ga) PSMA-11 INJECTION. 04/2021:3044. 11th ed. EDQM Council of Europe; Strasbourg, France: 2021.

European Pharmacopoeia . DEFEROXAMINE MESILATE. 01/2018:0896. 11th ed. EDQM Council of Europe; Strasbourg, France: 2018.

Petrik M., Zhai C., Haas H., Decristoforo C. Siderophores for Molecular Imaging Applications. Clin. Transl. Imaging. 2017;5:15–27. doi: 10.1007/s40336-016-0211-x. PubMed DOI PMC

Ioppolo J.A., Caldwell D., Beiraghi O., Llano L., Blacker M., Valliant J.F., Berti P.J. 67Ga-Labeled Deferoxamine Derivatives for Imaging Bacterial Infection: Preparation and Screening of Functionalized Siderophore Complexes. Nucl. Med. Biol. 2017;52:32–41. doi: 10.1016/j.nucmedbio.2017.05.010. PubMed DOI

Petrik M., Umlaufova E., Raclavsky V., Palyzova A., Havlicek V., Haas H., Novy Z., Dolezal D., Hajduch M., Decristoforo C. Imaging of Pseudomonas Aeruginosa Infection with Ga-68 Labelled Pyoverdine for Positron Emission Tomography. Sci. Rep. 2018;8:15698. doi: 10.1038/s41598-018-33895-w. PubMed DOI PMC

Lepareur N. Cold Kit Labeling: The Future of 68Ga Radiopharmaceuticals? Front. Med. 2022;9:812050. doi: 10.3389/fmed.2022.812050. PubMed DOI PMC

Petrik M., Knetsch P.A., Knopp R., Imperato G., Ocak M., von Guggenberg E., Haubner R., Silbernagl R., Decristoforo C. Radiolabelling of Peptides for PET, SPECT and Therapeutic Applications Using a Fully Automated Disposable Cassette System. Nucl. Med. Commun. 2011;32:887–895. doi: 10.1097/MNM.0b013e3283497188. PubMed DOI

de Blois E., Sze Chan H., Naidoo C., Prince D., Krenning E.P., Breeman W.A.P. Characteristics of SnO2-Based 68Ge/68Ga Generator and Aspects of Radiolabelling DOTA-Peptides. Appl. Radiat. Isot. 2011;69:308–315. doi: 10.1016/j.apradiso.2010.11.015. PubMed DOI

Desferal—Summary of Product Characteristics 2018. [(accessed on 20 September 2024)]. Available online: https://www.hpra.ie/img/uploaded/swedocuments/LicenseSPC_PA0013-065-001_09072018160137.pdf.

Serdons K., Verbruggen A., Bormans G. The presence of ethanol in radiopharmaceutical injections. J. Nucl. Med. 2008;49:2071. doi: 10.2967/jnumed.108.057026. PubMed DOI